Monopoly on COVID-19 treatment would be 'dangerously stupid,' MSF doctor says

When a treatment for the coronavirus becomes available, who would get access to it? This question is of growing concern to policymakers and medical officials around the globe. Dr. Manuel Martin, an advisor with Mi(C)decins Sans Frontiires, speaks with The World's Marco Werman about why a potential monopoly by one pharmaceutical company worries him.